Key result
miR-148a-3p protects vascular endothelial cells and alleviates CAD by downregulating PCSK9 in preclinical models.
Answers are grounded in this paper and cite their sources.
miR-148a-3p protects vascular endothelial cells and alleviates coronary artery disease in preclinical models by downregulating PCSK9 and inhibiting the NF-κB signaling pathway.
Coronary artery disease (CAD) causes myocardial ischemia, narrowing or occlusion of the lumen. Although great progress has been made in the treatment of CAD, the existing treatment methods do not meet the clinical needs, so it is urgent to find new treatment methods. The aim of this study was to investigate the mechanism of action of miR-148a-3p in alleviating CAD by inhibiting vascular endothelial cell injury and to provide new ideas for the treatment of CAD. A cell model was constructed by lipopolysaccharide (LPS) induction of vascular endothelial cells, and a CAD rat model was established by a high-fat diet and intraperitoneal injection of posterior pituitary hormone. Relevant indices were detected by RT-qPCR, ELISA, Western blot, MTT, and flow cytometry. The results indicate that in LPS-induced vascular endothelial cell assays, miR-148a-3p inhibited the upregulation of PCSK9, thereby suppressing the NF-κB signaling pathway and promoting vascular endothelial cell proliferation. Overexpression of PCSK9 and the addition of NF-κB signaling pathway activator increased vascular endothelial cell apoptosis. In animal experiments, miR-148a-3p alleviated the symptoms of CAD rats, whereas overexpression of PCSK9 promoted apoptosis and increased atheromatous plaque area in CAD rats. In conclusion, miR-148a-3p inhibits the NF-κB signaling pathway through downregulation of PCSK9, thereby protecting vascular endothelial cells and alleviating CAD.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2024) studied Coronary artery disease. miR-148a-3p was evaluated on Vascular endothelial cell injury and CAD symptoms. miR-148a-3p inhibited the NF-κB signaling pathway through downregulation of PCSK9, thereby protecting vascular endothelial cells and alleviating coronary artery disease in cell and rat models.
Synapse has enriched 10 related papers. Consider them for comparative context: